Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
Valliappan Muthu(Post Graduate Institute of Medical Education and Research), Ritesh Agarwal(Albert Einstein College of Medicine), Shivaprakash M. Rudramurthy(Post Graduate Institute of Medical Education and Research), Arunaloke Chakrabarti(Dev Sanskriti Vishwavidyalaya)
Cited by 227
Related Papers
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
|Clinical & Experimental Allergy|2013|895
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy
|Hepatology|2007|599
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature
|Mycopathologia|2021|590
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India
|Emerging infectious diseases|2021|479